2023-05-04 12:39:28 ET
- Editas Medicine ( NASDAQ: EDIT ) is scheduled to announce Q1 earnings results on Friday, May 5th, before market open.
- The consensus EPS Estimate is -$0.81 and the consensus Revenue Estimate is $3.29M (-51.4% Y/Y).
- Over the last 1 year, EDIT has beaten EPS estimates 75% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 4 downward. Revenue estimates have seen 1 upward revision and 0 downward.
For further details see:
Editas Medicine Q1 2023 Earnings Preview